KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Non-Current Deferred Tax Liability (2016)

Historic Non-Current Deferred Tax Liability for Biomarin Pharmaceutical (BMRN) over the last 6 years, with Q1 2016 value amounting to $143.5 million.

  • Biomarin Pharmaceutical's Non-Current Deferred Tax Liability fell 2571.14% to $143.5 million in Q1 2016 from the same period last year, while for Mar 2016 it was $143.5 million, marking a year-over-year decrease of 2571.14%. This contributed to the annual value of $143.5 million for FY2015, which is N/A changed from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Non-Current Deferred Tax Liability stood at $143.5 million for Q1 2016, which was down 2571.14% from $143.5 million recorded in Q4 2015.
  • Over the past 5 years, Biomarin Pharmaceutical's Non-Current Deferred Tax Liability peaked at $193.2 million during Q1 2015, and registered a low of $32.7 million during Q1 2012.
  • For the 4-year period, Biomarin Pharmaceutical's Non-Current Deferred Tax Liability averaged around $92.5 million, with its median value being $37.4 million (2013).
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first surged by 1475.01% in 2013, then crashed by 2571.14% in 2016.
  • Quarter analysis of 4 years shows Biomarin Pharmaceutical's Non-Current Deferred Tax Liability stood at $33.3 million in 2012, then rose by 11.7% to $37.2 million in 2013, then skyrocketed by 285.93% to $143.5 million in 2015, then changed by 0.0% to $143.5 million in 2016.
  • Its Non-Current Deferred Tax Liability was $143.5 million in Q1 2016, compared to $143.5 million in Q4 2015 and $193.2 million in Q3 2015.